The role of 14-3-3 proteins in calcium-sensing receptor-mediated Rho signalling
Arulpragasam, A., Ward, B. K., Magno, A. L., Ingley, E., Conigrave, A. D., & Ratajczak, T. (2010). The role of 14-3-3 proteins in calcium-sensing receptor-mediated Rho signalling. Australian Society for Medical Research Western Australia Scientific Symposium.
The calcium-sensing receptor (CaR) is pivotal in maintaining calcium homeostasis, but also regulates a number of other cellular processes. To achieve this, the CaR activates a number of different cell signalling pathways including Rho-dependent serum-response element (SRE) activation, which is enhanced by the partner binding protein, filamin. To provide further insight into mechanisms controlling CaR signalling, a yeast two-hybrid screen was performed using the CaR intracellular tail as bait. A number of interacting proteins were identified including the 14-3-3 isoforms theta and zeta. 14-3-3 proteins are chaperones which bind to numerous partner proteins, influencing a multitude of cellular processes, including cell signalling.
Yeast two-hybrid mapping studies delineated the interaction site for both 14-3-3 isoforms to residues 865-922 on the CaR tail, and co-immunoprecipitation studies confirmed CaR/14-3-3 theta and zeta in vivo interaction in mammalian cells. To investigate the possible role of 14-3-3 theta and zeta in CaR-mediated Rho signalling, HEK-293 cells stably expressing the CaR (HEK-293/CaR) were transfected with either 14-3-3 theta or zeta and an SRE luciferase reporter, which allowed for the measurement of SRE activation. Results demonstrated that over-expression of both 14-3-3 theta and zeta inhibited CaR-mediated SRE activation in these cells. This effect was not seen in CaR-transfected M2 cells unable to express filamin but was not restored in CaR-transfected M2 cells stably expressing filamin. We propose a mechanism whereby 14-3-3 theta and zeta either competitively bind with or sequester filamin leading to the inhibition of CaR-mediated SRE activation in HEK-293/CaR cells.
Oral Presentation, Abstract only